FI930860L - Tropolonderivat och farmaceutiska kompositioner saerav foer avvaerjning och behandling av iskemiska sjukdomar - Google Patents

Tropolonderivat och farmaceutiska kompositioner saerav foer avvaerjning och behandling av iskemiska sjukdomar Download PDF

Info

Publication number
FI930860L
FI930860L FI930860A FI930860A FI930860L FI 930860 L FI930860 L FI 930860L FI 930860 A FI930860 A FI 930860A FI 930860 A FI930860 A FI 930860A FI 930860 L FI930860 L FI 930860L
Authority
FI
Finland
Prior art keywords
och
tropolonderivat
saerav
iskemiska
farmaceutiska
Prior art date
Application number
FI930860A
Other languages
English (en)
Finnish (fi)
Other versions
FI930860A0 (fi
FI930860A7 (fi
Inventor
Noriie Itoh
Mineo Kunihara
Hiroshi Kushida
Jr William W Mcwhorter
Syunji Nomura
Kazunouri Ozawa
Mikio Taniguchi
Kazuo Tsuzuki
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2229536A external-priority patent/JPH04120069A/ja
Priority claimed from JP5625291A external-priority patent/JPH04247077A/ja
Priority claimed from JP3039173A external-priority patent/JPH04295471A/ja
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI930860L publication Critical patent/FI930860L/fi
Publication of FI930860A0 publication Critical patent/FI930860A0/fi
Publication of FI930860A7 publication Critical patent/FI930860A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
FI930860A 1990-08-29 1991-08-27 Tropolonijohdoksia ja niiden farmaseuttisia koostumuksia iskeemisten s airauksien ehkäisemiseen ja hoitamiseen FI930860A7 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2229536A JPH04120069A (ja) 1990-08-29 1990-08-29 トロポロン誘導体およびこれを有効成分とする虚血性疾患の予防・治療剤
JP5625291A JPH04247077A (ja) 1991-01-31 1991-01-31 トロポロン誘導体およびそれを有効成分とする虚血性疾患の予防・治療剤
JP3039173A JPH04295471A (ja) 1991-02-08 1991-02-08 トロポロン誘導体およびこれを有効成分とする虚血性疾患の予防・治療剤
PCT/US1991/005906 WO1992004338A1 (en) 1990-08-29 1991-08-27 Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases

Publications (3)

Publication Number Publication Date
FI930860L true FI930860L (fi) 1993-02-25
FI930860A0 FI930860A0 (fi) 1993-02-25
FI930860A7 FI930860A7 (fi) 1993-02-25

Family

ID=27290061

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930860A FI930860A7 (fi) 1990-08-29 1991-08-27 Tropolonijohdoksia ja niiden farmaseuttisia koostumuksia iskeemisten s airauksien ehkäisemiseen ja hoitamiseen

Country Status (14)

Country Link
US (1) US5594144A (de)
EP (1) EP0546102B1 (de)
JP (1) JP2512656B2 (de)
KR (1) KR100232324B1 (de)
AT (1) ATE159251T1 (de)
AU (1) AU651629B2 (de)
CA (1) CA2087004C (de)
DE (1) DE69127976T2 (de)
DK (1) DK0546102T3 (de)
ES (1) ES2109276T3 (de)
FI (1) FI930860A7 (de)
HU (2) HUT65943A (de)
NO (1) NO305801B1 (de)
WO (1) WO1992004338A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703071A (en) * 1990-08-29 1997-12-30 Pharmacia & Upjohn Company Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases
US5900426A (en) * 1995-03-28 1999-05-04 Nippon Zoki Pharmaceutical Co., Ltd. Benzothiazole derivatives
EP0929537A1 (de) * 1996-08-22 1999-07-21 Hoechst Marion Roussel, Inc. Troponyl piperazine als selektive dopamin d4 rezeptor liganden
US5998414A (en) * 1996-08-22 1999-12-07 Hoechst Marion Roussel, Inc. Troponyl piperazines as dopamine D4 receptor ligands
AU736510B2 (en) 1997-06-27 2001-07-26 Nippon Kayaku Kabushiki Kaisha Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives
EP1144387A1 (de) 1998-12-04 2001-10-17 Neurosearch A/S Benzimidazolon-, benzoxazolon- oder benzothiazolon-derivate als ionenkanal modulierende mittel
DK1395567T3 (da) 2001-05-18 2009-04-06 Astrazeneca Ab 4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser
US6689342B1 (en) * 2002-07-29 2004-02-10 Warner-Lambert Company Oral care compositions comprising tropolone compounds and essential oils and methods of using the same
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
DK1781631T3 (da) 2004-08-02 2012-05-14 Astrazeneca Ab Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
KR101036322B1 (ko) 2009-11-12 2011-05-23 한국과학기술연구원 히노키티올의 프롤릴 하이드록실라제 2 활성 저해 용도
FR2993462B1 (fr) * 2012-07-18 2014-10-17 Ct Eugene Marquis Composition a usage therapeutique comprenant une phrase organique lipidique et un complexe de terre rare radioisotopique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1153764A (en) * 1980-02-25 1983-09-13 Jehan F. Bagli 2-(1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
HUT65943A (en) 1994-08-29
JPH06509318A (ja) 1994-10-20
CA2087004A1 (en) 1992-03-01
HU9300533D0 (en) 1993-05-28
NO930669D0 (no) 1993-02-25
CA2087004C (en) 1998-04-21
ES2109276T3 (es) 1998-01-16
HU211307A9 (en) 1995-11-28
NO305801B1 (no) 1999-07-26
KR100232324B1 (ko) 1999-12-01
JP2512656B2 (ja) 1996-07-03
EP0546102A1 (de) 1993-06-16
AU8720391A (en) 1992-03-30
FI930860A0 (fi) 1993-02-25
US5594144A (en) 1997-01-14
NO930669L (no) 1993-02-25
DK0546102T3 (da) 1998-06-02
ATE159251T1 (de) 1997-11-15
DE69127976D1 (de) 1997-11-20
DE69127976T2 (de) 1998-03-05
EP0546102B1 (de) 1997-10-15
AU651629B2 (en) 1994-07-28
FI930860A7 (fi) 1993-02-25
WO1992004338A1 (en) 1992-03-19

Similar Documents

Publication Publication Date Title
FI931465L (fi) Anordning och foerfarande foer infoering av en aoderplugg
FI932960L (fi) Kontroll av frukters mogning och vaexters foeraoldring
FI924382A7 (fi) Foerfarande och anordning foer jontoforetisk avgivning av laekemedel
FI932932L (fi) Foerfarande och komposition foer desinfektering av kontaktlinser
FI932278L (fi) Foerfarande och komposition foer kontrollerad avgivning av biologiskt aktiva aemnen
FI924472L (fi) Foerfarande och komposition foer behandling av trombos
FI932082L (fi) Foerbaettringar i och angaoende fodrande av roerledningar
FI932762L (fi) Hydrogenperoxid foerstoerande kompositioner och foerfaranden foer framstaellning av desamma
FI923983A7 (fi) Kymotrypsinlika proteaser och deras inhibitorer
FI932451A7 (fi) Anordning foer maskintvaettning av klaeder och foerfarande foer anvaendning av naemnda anordning
FI925480L (fi) Vattenloeslig pentacyklisk triterpenkomposition och foerfarande foer framstaellning av densamma
FI923747L (fi) Kompositioner och foerfaranden foer behandling av infektioner foerorsakade av organismer sensitiva foer b-laktamantibiotika
FI924272A7 (fi) Foerfarande och anordning foer maskinbearbetning av valsar och liknande arbetsstycken
FI923864L (fi) Fodermaterial foer roerledning och roerkanal
FI930905L (fi) Foerfarande foer uppsamling och behandling av icke-vattenhaltiga droppvaetskor
FI88433C (fi) Anordning foer ingaongs- och utgaongsluft och luftkonditioneringsfoerfarande
FI925052L (fi) Foerfarande foer kontinuerlig framstaellning av sanitetsprodukter saosom bloejbyxor och saolunda framstaelld sanitetsprodukt
FI923814L (fi) Foerfarande foer oevervakning och reglering av primaer kaernbildning av jaernsmaeltor
FI923999A7 (fi) Foerfarande och anordning foer rengoering av roerledningar
FI930860L (fi) Tropolonderivat och farmaceutiska kompositioner saerav foer avvaerjning och behandling av iskemiska sjukdomar
FI925692A7 (fi) Foerfarande och anordning foer testning och oevervakning av majoritetsroestning
FI924713L (fi) Foerfarande foer saollning av proteinpartner och anvaendning av dessa
FI932568L (fi) Vaetskeavledningspaose innehaollande absorbermedel och foerfarande foer anvaendning av densamma
FI925453L (fi) Lipasderivat stimulerade av maenniskans gallsalter och farmaceutiska aemnen innehaollande daerav
FI924094L (fi) Foerfarande foer framstaellning av skyddsgas och gasblandning foer detta

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN COMPANY

FD Application lapsed